Held in conjunction with the 16th International Parallel and Distributed Processing Symposium Copyright © 2002 IEEE – All Rights ReservedThe persistence of human immunodeficiency virus type 1 (HIV-1) infection may be in part attributed to its ability to evolve to evade neutralizing antibody (NAb) surveillance. We have tested the prediction that positive selection of V3 is positively correlated with the strength of a patient’s NAb response by analyzing a data set containing both sequences from the principal neutralizing domain of HIV-1 (V3) and measures of the strength of the NAb responses of several patients. Only viral sequences from the patient with the strongest NAb response exhibited evidence of significant positive selection. To invest...
The Human immunodeficiency virus (HIV) pandemic has resulted in a heavy global disease burden, and c...
Author Summary Most HIV-1 infected individuals develop neutralizing antibodies against their own vir...
AbstractBroadly neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) are cons...
AbstractThe origin of broadly neutralizing HIV-specific antibodies and their relation to HIV evoluti...
Broadly neutralizing antibodies are promising candidates for treatment and prevention of HIV-1 infec...
In the absence of effective antiviral therapy, HIV-1 evolves in response to the within-host environm...
Advances in single cell antibody cloning methods have led to the identification of a variety of bro...
BACKGROUND: The evolution of HIV-1 and its immune escape to autologous neutralizing antibodies (Nabs...
Background: Identification of the epitopes targeted by antibodies that can neutralize diverse HIV-1 ...
In the absence of effective antiviral therapy, HIV-1 evolves in response to the within-host environm...
Recent evidence of the evolutionary adaptation of HIV-1 to the specific immune system is reviewed. L...
Background: Identification of the epitopes targeted by antibodies that can neutralize diverse HIV-1 ...
Human immunodeficiency virus (HIV) evolves within infected persons to escape being destroyed by the ...
AbstractAutologous HIV-1-specific neutralizing antibodies (NAbs) seem unable to inhibit viral replic...
Hypotheses have been put forward suggesting that immune selection generates much of the intra-patien...
The Human immunodeficiency virus (HIV) pandemic has resulted in a heavy global disease burden, and c...
Author Summary Most HIV-1 infected individuals develop neutralizing antibodies against their own vir...
AbstractBroadly neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) are cons...
AbstractThe origin of broadly neutralizing HIV-specific antibodies and their relation to HIV evoluti...
Broadly neutralizing antibodies are promising candidates for treatment and prevention of HIV-1 infec...
In the absence of effective antiviral therapy, HIV-1 evolves in response to the within-host environm...
Advances in single cell antibody cloning methods have led to the identification of a variety of bro...
BACKGROUND: The evolution of HIV-1 and its immune escape to autologous neutralizing antibodies (Nabs...
Background: Identification of the epitopes targeted by antibodies that can neutralize diverse HIV-1 ...
In the absence of effective antiviral therapy, HIV-1 evolves in response to the within-host environm...
Recent evidence of the evolutionary adaptation of HIV-1 to the specific immune system is reviewed. L...
Background: Identification of the epitopes targeted by antibodies that can neutralize diverse HIV-1 ...
Human immunodeficiency virus (HIV) evolves within infected persons to escape being destroyed by the ...
AbstractAutologous HIV-1-specific neutralizing antibodies (NAbs) seem unable to inhibit viral replic...
Hypotheses have been put forward suggesting that immune selection generates much of the intra-patien...
The Human immunodeficiency virus (HIV) pandemic has resulted in a heavy global disease burden, and c...
Author Summary Most HIV-1 infected individuals develop neutralizing antibodies against their own vir...
AbstractBroadly neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) are cons...